Vizen Life Sciences Pvt Ltd’s Post

View organization page for Vizen Life Sciences Pvt Ltd, graphic

13,223 followers

Two new quality standards, one for MDMA and another for psilocybine, have been published. These standards each specify the minimum quality requirements for both the active pharmaceutical ingredient (API) and finished product. From 6 January 2025, all MDMA and psilocybine API and finished products supplied or manufactured in Australia must comply with the relevant TGO. Read more: https://lnkd.in/gNDrfTyi

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics